Avidity Biosciences, Inc. (RNA)
USD 26.91
(5.2%)
USD 26.91
(5.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.56 Million | 9.22 Million | 9.32 Million | 6.78 Million | 2.31 Million | 379 Thousand |
| Cost of Revenue | 190.96 Million | 1.38 Million | 639 Thousand | 37.6 Million | 14.53 Million | 8.43 Million |
| Gross Profit | -181.4 Million | 7.83 Million | 8.68 Million | -30.81 Million | -12.22 Million | -8.05 Million |
| Operating Expenses | 245.15 Million | 188.13 Million | 127.37 Million | 51.06 Million | 19.65 Million | 10.87 Million |
| Selling, General and Administrative Expenses | 54.19 Million | 37.73 Million | 26.19 Million | 13.46 Million | 5.11 Million | 2.44 Million |
| Research and Development Expenses | 190.96 Million | 150.4 Million | 101.18 Million | 37.6 Million | 14.53 Million | 8.43 Million |
| Other Expenses | - | 4.91 Million | 42 Thousand | -78 Thousand | - | - |
| Cost and Expenses | 245.15 Million | 188.13 Million | 127.37 Million | 51.06 Million | 19.65 Million | 10.87 Million |
| Operating Income | -235.59 Million | -178.91 Million | -118.05 Million | -44.27 Million | -17.33 Million | -10.49 Million |
| Interest Expense | - | - | - | 209 Thousand | 7.38 Million | 718 Thousand |
| Income Tax Expense | - | -4.91 Million | -639 Thousand | -373 Thousand | 7.38 Million | 718 Thousand |
| Earnings before Tax | -212.22 Million | -173.99 Million | -118 Million | -44.35 Million | -24.73 Million | -11.21 Million |
| Net Income | -212.22 Million | -169.07 Million | -117.37 Million | -43.98 Million | -32.12 Million | -11.93 Million |
| Earnings Per Share Basic | -2.91 | -3.24 | -2.83 | -2.03 | -0.86 | -0.58 |
| Earnings Per Share Diluted | -2.91 | -3.24 | -2.83 | -2.03 | -0.86 | -0.58 |
| Weighted Average Shares Outstanding | 73.01 Million | 52.16 Million | 41.42 Million | 21.66 Million | 37.51 Million | 20.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.01 Million | 52.16 Million | 41.42 Million | 21.66 Million | 37.51 Million | 20.68 Million |
| Gross Margin | -18.98 | 0.85 | 0.93 | -4.54 | -5.27 | -21.26 |
| EBIT Margin | -24.42 | -19.40 | -12.66 | -6.52 | -7.32 | -26.69 |
| Profit Margin | -22.20 | -18.33 | -12.59 | -6.48 | -13.85 | -31.49 |
| EBITDA | -233.49 Million | -177.52 Million | -117.41 Million | -43.77 Million | -16.75 Million | -10.11 Million |
| Earnings Before Tax Margin | -24.64 | -19.40 | -12.66 | -6.52 | -7.47 | -27.70 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.04 Million | 3.54 Million | 9.56 Million | 2.19 Million | 2.81 Million | 2.31 Million |
| Cost of Revenue | 687 Thousand | 641 Thousand | 2.1 Million | 615 Thousand | 1.3 Million | 1.26 Million |
| Gross Profit | 1.35 Million | 2.9 Million | 7.45 Million | 1.57 Million | 1.51 Million | 1.05 Million |
| Operating Expenses | 83.98 Million | 80.08 Million | 243.05 Million | 68.32 Million | 61.44 Million | 54.95 Million |
| Selling, General and Administrative Expenses | 20.04 Million | 13.25 Million | - | 15.5 Million | 13.72 Million | 12.27 Million |
| Research and Development Expenses | 63.94 Million | 66.83 Million | - | 52.81 Million | 47.71 Million | 42.67 Million |
| Other Expenses | -116 Thousand | -101 Thousand | -594 Thousand | -105 Thousand | -13 Thousand | -162 Thousand |
| Cost and Expenses | 84.67 Million | 80.73 Million | 245.15 Million | 68.93 Million | 61.44 Million | 54.95 Million |
| Operating Income | -82.62 Million | -77.18 Million | -235.59 Million | -66.74 Million | -58.62 Million | -52.63 Million |
| Interest Expense | - | - | - | 391 Thousand | - | - |
| Income Tax Expense | - | 597.72 Thousand | 1.93 Million | -1.00 | -6.28 Million | -5.77 Million |
| Earnings before Tax | -70.79 Million | -68.85 Million | -212.22 Million | -60.44 Million | -52.35 Million | -47.02 Million |
| Net Income | -70.79 Million | -68.85 Million | -212.22 Million | -60.44 Million | -52.35 Million | -47.02 Million |
| Earnings Per Share Basic | -0.66 | -0.79 | - | -0.79 | -0.71 | -0.66 |
| Earnings Per Share Diluted | -0.66 | -0.79 | - | -0.79 | -0.71 | -0.66 |
| Weighted Average Shares Outstanding | 106.92 Million | 87.21 Million | 73.01 Million | 76.05 Million | 74.09 Million | 71.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.92 Million | 87.21 Million | 73.01 Million | 76.05 Million | 74.09 Million | 71.39 Million |
| Gross Margin | 0.66 | 0.82 | 0.78 | 0.72 | 0.54 | 0.46 |
| EBIT Margin | -40.07 | -21.60 | - | -30.15 | -20.60 | -22.50 |
| Profit Margin | -34.62 | -19.43 | -22.20 | -27.56 | -18.58 | -20.30 |
| EBITDA | -81.93 Million | -76.54 Million | - | -66.12 Million | -58.05 Million | -52.1 Million |
| Earnings Before Tax Margin | -40.40 | -21.79 | -24.64 | -30.43 | -20.80 | -22.73 |
002152
IVT
EAM
603693
HEINY
MSRM